NEW YORK (360Dx) – A team of researchers at the University of Toronto have developed a compact and portable surveillance device that identifies populations vulnerable to vaccine-preventable diseases in areas that lack a centralized laboratory.

The team applied the digital microfluidics (DMF) platform for the first time outside the laboratory in Kenya in order to detect cases of measles and rubella in refugee populations.

Get the full story with
360Dx Premium

Only $95 for the
first 90 days*

360Dx Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try 360Dx Premium now.

You may already have institutional access!

Check if I qualify.

Already a 360Dx or GenomeWeb Premium member?
Login Now.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.